SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Clinical trial NCT03262935 · COMPLETED
Trial details
- NCT number
- NCT03262935
- Sponsor
- Byondis B.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-15
- Primary completion
- 2021-03-31
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.